Cargando…
Rapid subcutaneous progression after immunotherapy in pretreated patients with metastatic carcinoma: two case reports
There is heterogeneity in cancer patients’ responses to immune checkpoint inhibitors (ICIs), including hyperprogression, which is very rapid tumor progression following immunotherapy, and pseudoprogression, which is an initial increase followed by a decrease in tumor burden or in the number of tumor...
Autores principales: | Da, Yong, Shen, Ge, Zhou, Ming, Wang, Tao, Dong, Dapeng, Bu, Lina, Shao, Yun, Sun, Qiyun, Yu, Ruoying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087252/ https://www.ncbi.nlm.nih.gov/pubmed/35469479 http://dx.doi.org/10.1177/03000605221094274 |
Ejemplares similares
-
Isolated Subcutaneous Mass of the Scalp as Initial Presentation of Metastatic Squamous Cell Carcinoma of the Lung
por: Kuykendall, Lauren V., et al.
Publicado: (2013) -
Immunotherapy for metastatic liver disease from colorectal carcinoma: case series from the Middle East
por: Kakati, Rasha T, et al.
Publicado: (2022) -
Subcutaneous sarcoidosis: A case series of 19 patients
por: Lopez-Sundh, AE, et al.
Publicado: (2021) -
Rush immunotherapy in two cats with atopic skin syndrome
por: Jones, Selene, et al.
Publicado: (2021) -
Selinexor, Bortezomib and Dexamethasone: An Effective Salvage Regimen for Heavily Pretreated Myeloma Patients
por: Delforge, Michel, et al.
Publicado: (2022)